相关实验视频
Updated: Jan 16, 2026

13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
24.7K
肝炎C病毒相关心肌病:病变发生的综述
Inderjeet Singh Bharaj1, Gurkaranvir Singh2, Ajit Singh Brar3
1Department of Internal Medicine, Abrazo Health Network, Glendale, AZ 85308, United States.
World journal of virology
|September 30, 2025
概括
肝炎C病毒 (HCV) 通过病毒,免疫和代谢途径引起心肌病,而肝硬化通常会使病情恶化. 直接作用抗病毒药物 (DAA) 疗法改善了心脏健康,并减少了受影响患者的心血管事件.
科学领域:
- 心脏病学 心脏病学
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 型肝炎病毒 (HCV) 感染与扩张性和多变性心肌病相关.
- 病原发生涉及复杂的病毒,免疫和代谢机制,由肝硬化加剧.
- 这会增加感染者心血管疾病的发病率.
研究的目的:
- 审查C型肝炎病毒 (HCV) 患者心肌病的发病性.
- 研究HCV相关心肌病的临床影响.
- 探索治疗对心血管结果的影响.
主要方法:
- 使用PubMed,Scopus和谷歌学者进行了叙事文献审查.
- 搜索了1990年至2024年间发表的英语研究.
- 对HCV-心肌病链接,病理生理学和治疗的发现进行了定性合成.
主要成果:
- 型冠状病毒通过直接的病毒毒性,免疫损伤,遗传因素和亡诱导心肌病.
- 肝硬化通过肝硬化的心肌病变机制,增加心血管事件.
- 直接作用抗病毒药物 (DAA) 通过减少不良事件和增强心脏功能来改善心血管结果.
结论:
- 型肝炎是心肌病的重要危险因素,涉及多种途径,包括肝硬化.
- 在患有HCV的患者中,DAA疗法对心血管有好处.
- 需要对机制,生物标志物 (M2BPGi,Ang-2) 和全球DAA访问进行进一步的研究.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
411
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
411
Myocarditis I: Introduction
374
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
374
Cardiomyopathy I: Introduction and Classification
504
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
504
Cardiomyopathy II: Dilated Cardiomyopathy
470
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
470
Myocarditis III: Medical Management
175
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
175
Pathophysiology of Heart Failure
2.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.9K

